Company Filing History:
Years Active: 2025
Title: Mikyung Chang: Innovator in Cancer Treatment
Introduction
Mikyung Chang is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of cancer treatment through his innovative research and development.
Latest Patents
Mikyung Chang holds a patent for an "Anti-BCMA antibody and use thereof." This invention provides an antibody or antigen-binding fragment that specifically binds to a B-cell maturation antigen (BCMA). The method of preparing this antibody and its applications are crucial for effectively preventing or treating cancers. He has 1 patent to his name.
Career Highlights
Mikyung Chang is associated with Abl Bio Inc., a company focused on developing innovative therapies. His work at Abl Bio Inc. emphasizes the importance of targeted cancer treatments, showcasing his commitment to advancing medical science.
Collaborations
Mikyung Chang collaborates with talented individuals such as Kyungjin Park and Hyejin Chung. Their combined expertise contributes to the success of their projects and enhances the research environment at Abl Bio Inc.
Conclusion
Mikyung Chang's contributions to cancer treatment through his patented innovations highlight his role as a leading inventor in the field. His work continues to inspire advancements in medical research and therapy development.